Human Genetics

, Volume 137, Issue 3, pp 265–277 | Cite as

Next-generation sequencing reveals genetic landscape in 46, XY disorders of sexual development patients with variable phenotypes

  • Hao Wang
  • Lele Zhang
  • Nan Wang
  • Hui Zhu
  • Bing Han
  • Feng Sun
  • Haijun Yao
  • Qiang Zhang
  • Wenjiao Zhu
  • Tong Cheng
  • Kaixiang Cheng
  • Yang Liu
  • Shuangxia Zhao
  • Huaidong Song
  • Jie Qiao
Original Investigation

Abstract

Disorders of sexual development (DSD) are rare congenital conditions in which chromosomal, gonadal, or anatomical sex is atypical. Currently, less than 20% of patients receive an accurate genetic diagnosis. Targeted next-generation sequencing, consisting of 33 candidate genes and 47 genes involved in sexual differentiation and development, was performed on 70 46, XY DSD patients. Functional assays were performed to evaluate the expression and transcriptional activity of one reported and nine novel mutations of NR5A1. In total, 113 mutations, including 86 novel and 27 reported sites in 40 genes, were identified in 52 patients. Among them, 37 mutations from 19 genes were first identified in 46, XY DSD patients, including EGF, LHX9, and CST9. Nine patients displayed biallelic mutations, 12 had mutations in sex chromosome genes and 14 had monoallelic mutations in NR5A1, BMP4, and WT1. Higher frequency mutations were identified in AR, SRD5A2, and NR5A1. Six missense, one frameshift, and one three-nucleotide deletion mutations of NR5A1 were shown to impair the transactivation ability with an altered nuclear aggregation of p.T29K and p.N44del variants. Multiple genetic mutations were identified in 33 of the 70 patients. The targeted sequencing panel provides an efficient method for the etiological diagnosis of 46, XY DSD patients and expands the candidate genes and inherited patterns.

Notes

Acknowledgements

We are grateful to the patients and their families for their supporting and participation in this study.

Author contributions

HW, LZ, and NW contributed equally to this work. HW, LZ, and FS performed the targeted exome sequencing and sequencing data analysis. Prediction of variants, verification by Sanger sequencing, and cell culture experiments was completed by HW and NW. BH completed protein structural analysis. HZ, BH, HY, WZ, TC, QZ, KC, and YL performed recruitment of patients, collected, and interpreted clinical data. SZ and HW did the statistical analysis. HS and JQ conceived and designed the experiments and revised the manuscript. All authors have seen and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

439_2018_1879_MOESM1_ESM.pdf (528 kb)
Supplementary material 1 (PDF 527 kb)

References

  1. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL (1999) A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125–126.  https://doi.org/10.1038/9629 CrossRefPubMedGoogle Scholar
  2. Andersson S, Berman DM, Jenkins EP, Russell DW (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354:159–161.  https://doi.org/10.1038/354159a0 CrossRefPubMedPubMedCentralGoogle Scholar
  3. Arboleda VA, Sandberg DE, Vilain E (2014) DSDs: genetics, underlying pathologies and psychosexual differentiation. Nat Rev Endocrinol 10:603–615.  https://doi.org/10.1038/nrendo.2014.130 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Baetens D, Stoop H, Peelman F, Todeschini AL, Rosseel T, Coppieters F, Veitia RA, Looijenga LH, De Baere E, Cools M (2016) NR5A1 is a novel disease gene for 46, XX testicular and ovotesticular disorders of sex development. Genet Med.  https://doi.org/10.1038/gim.2016.118 PubMedPubMedCentralGoogle Scholar
  5. Baetens D, Güran T, Mendonca BB, Gomes NL, De Cauwer L, Peelman F, Verdin H, Vuylsteke M, Van der Linden M, Atay Z, Bereket A, de Krijger RR, Preter Kd, Domenice S, Turan S, Stoop H, Looijenga LH, De Bosscher K, Cools M, De Baere E (2017) Biallelic and monoallelic ESR2 variants associated with 46, XY disorders of sex development. Genet Med.  https://doi.org/10.1038/gim.2017.163 Google Scholar
  6. Bashamboo A, Ferraz-de-Souza B, Lourenco D, Lin L, Sebire NJ, Montjean D, Bignon-Topalovic J, Mandelbaum J, Siffroi JP, Christin-Maitre S, Radhakrishna U, Rouba H, Ravel C, Seeler J, Achermann JC, McElreavey K (2010) Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet 87:505–512.  https://doi.org/10.1016/j.ajhg.2010.09.009 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Baxter RM, Arboleda VA, Lee H, Barseghyan H, Adam MP, Fechner PY, Bargman R, Keegan C, Travers S, Schelley S, Hudgins L, Mathew RP, Stalker HJ, Zori R, Gordon OK, Ramos-Platt L, Pawlikowska-Haddal A, Eskin A, Nelson SF, Delot E, Vilain E (2015) Exome sequencing for the diagnosis of 46, XY disorders of sex development. J Clin Endocrinol Metab 100:E333–E344.  https://doi.org/10.1210/jc.2014-2605 CrossRefPubMedGoogle Scholar
  8. Biason-Lauber A, Schoenle EJ (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67:1563–1568.  https://doi.org/10.1086/316893 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Biason-Lauber A, Konrad D, Meyer M, DeBeaufort C, Schoenle EJ (2009) Ovaries and female phenotype in a girl with 46, XY karyotype and mutations in the CBX2 gene. Am J Hum Genet 84:658–663.  https://doi.org/10.1016/j.ajhg.2009.03.016 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Birk OS, Casiano DE, Wassif CA, Cogliati T, Zhao L, Zhao Y, Grinberg A, Huang S, Kreidberg JA, Parker KL, Porter FD, Westphal H (2000) The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 403:909–913.  https://doi.org/10.1038/35002622 CrossRefPubMedGoogle Scholar
  11. Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ (1988) Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci USA 85:8151–8155CrossRefPubMedPubMedCentralGoogle Scholar
  12. Canto P, Soderlund D, Reyes E, Mendez JP (2004) Mutations in the desert hedgehog (DHH) gene in patients with 46, XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab 89:4480–4483.  https://doi.org/10.1210/jc.2004-0863 CrossRefPubMedGoogle Scholar
  13. Chen T, Li Q, Xu J, Ding K, Wang Y, Wang W, Li S, Shen Y (2007) Mutation screening of BMP4, BMP7, HOXA4 and HOXB6 genes in Chinese patients with hypospadias. Eur J Hum Genet 15:23–28.  https://doi.org/10.1038/sj.ejhg.5201722 CrossRefPubMedGoogle Scholar
  14. Eggers S, Sadedin S, van den Bergen JA, Robevska G, Ohnesorg T, Hewitt J, Lambeth L, Bouty A, Knarston IM, Tan TY, Cameron F, Werther G, Hutson J, O’Connell M, Grover SR, Heloury Y, Zacharin M, Bergman P, Kimber C, Brown J, Webb N, Hunter MF, Srinivasan S, Titmuss A, Verge CF, Mowat D, Smith G, Smith J, Ewans L, Shalhoub C, Crock P, Cowell C, Leong GM, Ono M, Lafferty AR, Huynh T, Visser U, Choong CS, McKenzie F, Pachter N, Thompson EM, Couper J, Baxendale A, Gecz J, Wheeler BJ, Jefferies C, MacKenzie K, Hofman P, Carter P, King RI, Krausz C, van Ravenswaaij-Arts CM, Looijenga L, Drop S, Riedl S, Cools M, Dawson A, Juniarto AZ, Khadilkar V, Khadilkar A, Bhatia V, Dung VC, Atta I, Raza J, Thi Diem Chi N, Hao TK, Harley V, Koopman P, Warne G, Faradz S, Oshlack A, Ayers KL, Sinclair AH (2016) Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol 17:243.  https://doi.org/10.1186/s13059-016-1105-y CrossRefPubMedPubMedCentralGoogle Scholar
  15. Eriksson A, Tohonen V, Wedell A, Nordqvist K (2002) Isolation of the human testatin gene and analysis in patients with abnormal gonadal development. Mol Hum Reprod 8:8–15CrossRefPubMedGoogle Scholar
  16. Fan JY, Han B, Qiao J, Liu BL, Ji YR, Ge SF, Song HD, Fan XQ (2010) Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Mutagenesis 26:283–289.  https://doi.org/10.1093/mutage/geq086 CrossRefPubMedGoogle Scholar
  17. Fan Y, Zhang X, Wang L, Wang R, Huang Z, Sun Y, Yao R, Huang X, Ye J, Han L, Qiu W, Zhang H, Liang L, Gu X, Yu Y (2017) Diagnostic application of targeted next-generation sequencing of 80 genes associated with disorders of sexual development. Sci Rep 7:44536.  https://doi.org/10.1038/srep44536 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskjold A, Camerino G, Kretz C, Buj-Bello A, Laporte J, Yamada G, Morohashi K, Ogata T (2006) CXorf6 is a causative gene for hypospadias. Nat Genet 38:1369–1371.  https://doi.org/10.1038/ng1900 CrossRefPubMedGoogle Scholar
  19. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW, Andersson S (1994) Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 7:34–39.  https://doi.org/10.1038/ng0594-34 CrossRefPubMedGoogle Scholar
  20. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA (1999) Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 3:521–526CrossRefPubMedGoogle Scholar
  21. Haraguchi R, Suzuki K, Murakami R, Sakai M, Kamikawa M, Kengaku M, Sekine K, Kawano H, Kato S, Ueno N, Yamada G (2000) Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development 127:2471–2479PubMedGoogle Scholar
  22. Imbeaud S, Faure E, Lamarre I, Mattei MG, di Clemente N, Tizard R, Carre-Eusebe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart JM, Lababidi A, Josso N, Cate RL, Picard JY (1995) Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nat Genet 11:382–388.  https://doi.org/10.1038/ng1295-382 CrossRefPubMedGoogle Scholar
  23. Kagimoto M, Winter JS, Kagimoto K, Simpson ER, Waterman MR (1988) Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency. Mol Endocrinol 2:564–570.  https://doi.org/10.1210/mend-2-6-564 CrossRefPubMedGoogle Scholar
  24. Kalfa N, Fukami M, Philibert P, Audran F, Pienkowski C, Weill J, Pinto G, Manouvrier S, Polak M, Ogata T, Sultan C (2012) Screening of MAMLD1 mutations in 70 children with 46, XY DSD: identification and functional analysis of two new mutations. PLoS One 7:e32505.  https://doi.org/10.1371/journal.pone.0032505 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Kim JH, Kang E, Heo SH, Kim G-H, Jang J-H, Cho E-H, Lee BH, Yoo H-W, Choi J-H (2017) Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development. Mol Cell Endocrinol 444:19–25.  https://doi.org/10.1016/j.mce.2017.01.037 CrossRefPubMedGoogle Scholar
  26. Knebelmann B, Boussin L, Guerrier D, Legeai L, Kahn A, Josso N, Picard JY (1991) Anti-Mullerian hormone Bruxelles: a nonsense mutation associated with the persistent Mullerian duct syndrome. Proc Natl Acad Sci USA 88:3767–3771CrossRefPubMedPubMedCentralGoogle Scholar
  27. Kohler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, Schroder V, Biebermann H, Schnabel D, Gruters A, Achermann JC (2008) Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46, XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat 29:59–64.  https://doi.org/10.1002/humu.20588 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA (2005) The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 25:1879–1890.  https://doi.org/10.1128/MCB.25.5.1879-1890.2005 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A, Molini V, Sebire NJ, Einaudi S, Conway GS, Hughes IA, Jameson JL, Sultan C, Dattani MT, Achermann JC (2007) Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46, XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 92:991–999.  https://doi.org/10.1210/jc.2006-1672 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Lourenco D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, Boudjenah R, Guerra-Junior G, Maciel-Guerra AT, Achermann JC, McElreavey K, Bashamboo A (2009) Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 360:1200–1210.  https://doi.org/10.1056/NEJMoa0806228 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay’s K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Gruters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nunez CJ, Servant N, Lumbroso S, Paris F, Sultan C (2011) Phenotypical, biological, and molecular heterogeneity of 5alpha-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 96:296–307.  https://doi.org/10.1210/jc.2010-1024 CrossRefPubMedGoogle Scholar
  32. Ostrer H (2014) Disorders of sex development (DSDs): an update. J Clin Endocrinol Metab 99:1503–1509.  https://doi.org/10.1210/jc.2013-3690 CrossRefPubMedGoogle Scholar
  33. Ottolenghi C, Moreira-Filho C, Mendonca BB, Barbieri M, Fellous M, Berkovitz GD, McElreavey K (2001) Absence of mutations involving the LIM homeobox domain gene LHX9 in 46, XY gonadal agenesis and dysgenesis. J Clin Endocrinol Metab 86:2465–2469.  https://doi.org/10.1210/jcem.86.6.7539 CrossRefPubMedGoogle Scholar
  34. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271–321.  https://doi.org/10.1210/edrv-16-3-271 PubMedGoogle Scholar
  35. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424.  https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
  36. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN (1990) A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240–244.  https://doi.org/10.1038/346240a0 CrossRefPubMedGoogle Scholar
  37. Tohonen V, Osterlund C, Nordqvist K (1998) Testatin: a cystatin-related gene expressed during early testis development. Proc Natl Acad Sci USA 95:14208–14213CrossRefPubMedPubMedCentralGoogle Scholar
  38. van der Zanden LF, van Rooij IA, Feitz WF, Franke B, Knoers NV, Roeleveld N (2012) Aetiology of hypospadias: a systematic review of genes and environment. Hum Reprod Update 18:260–283.  https://doi.org/10.1093/humupd/dms002 CrossRefPubMedGoogle Scholar
  39. Wang Y, Li Q, Xu J, Liu Q, Wang W, Lin Y, Ma F, Chen T, Li S, Shen Y (2004) Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur J Hum Genet 12:706–712.  https://doi.org/10.1038/sj.ejhg.5201232 CrossRefPubMedGoogle Scholar
  40. Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, Shelloe R, Mehra U, Eng K, Nguyen H, Settachatgul C, Powell B, Milburn MV, West BL (2005) The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci USA 102:7505–7510.  https://doi.org/10.1073/pnas.0409482102 CrossRefPubMedPubMedCentralGoogle Scholar
  41. Weiss J, Meeks JJ, Hurley L, Raverot G, Frassetto A, Jameson JL (2003) Sox3 is required for gonadal function, but not sex determination, in males and females. Mol Cell Biol 23:8084–8091.  https://doi.org/10.1128/mcb.23.22.8084-8091.2003 CrossRefPubMedPubMedCentralGoogle Scholar
  42. Wilhelm D, Englert C (2002) The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 16:1839–1851.  https://doi.org/10.1101/gad.220102 CrossRefPubMedPubMedCentralGoogle Scholar
  43. Zhu H, Liu W, Han B, Fan M, Zhao S, Wang H, Lu Y, Pan C, Chen F, Chen M, Song H, Cheng K, Qiao J (2014) Phenotypic and molecular characteristics in eleven Chinese patients with 5alpha-reductase type 2 deficiency. Clin Endocrinol (Oxf) 81:711–720.  https://doi.org/10.1111/cen.12456 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Endocrinology, Shanghai Ninth People’s HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
  2. 2.Research Centre for Clinical Medicine, Shanghai Ninth People’s HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
  3. 3.Department of Urology, Shanghai Ninth People’s HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
  4. 4.Department of Plastic Surgery, Shanghai Ninth People’s HospitalShanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations